Guarantor and Non-Guarantor Financial Statements (Details) - USD ($) | 3 Months Ended | 12 Months Ended | | | | | | | |
Dec. 31, 2016 | Sep. 30, 2016 | Jun. 30, 2016 | Mar. 31, 2016 | Dec. 31, 2015 | Sep. 30, 2015 | Jun. 30, 2015 | Mar. 31, 2015 | Dec. 31, 2016 | Dec. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2016 | Jun. 01, 2016 | May 15, 2016 | Dec. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2013 | May 23, 2012 |
Current assets: | | | | | | | | | | | | | | | | | | | |
Cash and cash equivalents | | $ 55,200,000 | | | $ 72,500,000 | $ 72,500,000 | | | $ 177,700,000 | $ 72,500,000 | $ 177,700,000 | $ 169,500,000 | $ 55,200,000 | | | $ 72,500,000 | $ 177,700,000 | $ 169,500,000 | |
Short-term investments | | | | | | | | | | | | | 231,000,000 | | | 30,000,000 | | | |
Receivables: | | | | | | | | | | | | | | | | | | | |
Trade, less allowance for doubtful receivables | | | | | | | | | | | | | 137,700,000 | | | 116,700,000 | | | |
Intercompany receivables | | | | | | | | | | | | | 0 | | | 0 | | | |
Other | | | | | | | | | | | | | 11,900,000 | | | 6,100,000 | | | |
Inventories | | | | | | | | | | | | | 201,600,000 | | | 219,600,000 | | | |
Prepaid expenses and other current assets | [1] | | | | | | | | | | | | 18,500,000 | | | 56,700,000 | | | |
Total current assets | | | | | | | | | | | | | 655,900,000 | | | 501,600,000 | | | |
Investments in and advances to unconsolidated affiliates | | | | | | | | | | | | | 0 | | | 0 | | | |
Property, plant and equipment – net | | | | | | | | | | | | | 530,900,000 | | | 495,400,000 | | | |
Long-term intercompany receivables | | | | | | | | | | | | | 0 | | | 0 | | | |
Deferred tax assets — net | [1],[2] | | | | | | | | | | | | 159,700,000 | | | 162,600,000 | | | |
Intangible assets – net | | | | | | | | | | | | | 26,400,000 | | | 30,500,000 | | | |
Goodwill | | | | | | | | | | | | | 37,200,000 | | | 37,200,000 | | | |
Other assets | [1] | | | | | | | | | | | | 33,400,000 | | | 19,600,000 | | | |
Total | | | | | | | | | | | | | 1,443,500,000 | | | 1,246,900,000 | | | |
Current liabilities: | | | | | | | | | | | | | | | | | | | |
Accounts payable | | | | | | | | | | | | | 75,800,000 | | | 76,700,000 | | | |
Intercompany payable | | | | | | | | | | | | | 0 | | | 0 | | | |
Accrued salaries, wages and related expenses | | | | | | | | | | | | | 49,100,000 | | | 39,800,000 | | | |
Other accrued liabilities | | | | | | | | | | | | | 39,900,000 | | | 52,700,000 | | | |
Short-term capital leases | | | | | | | | | | | | | 200,000 | | | 100,000 | | | |
Total current liabilities | | | | | | | | | | | | | 165,000,000 | | | 169,300,000 | | | |
Net liabilities of Salaried VEBA | | | | | | | | | | | | | 28,600,000 | | | 19,000,000 | | | |
Deferred tax liabilities | | | | | | | | | | | | | 3,300,000 | | | 2,100,000 | | | |
Long-term intercompany payable | | | | | | | | | | | | | 0 | | | 0 | | | |
Long-term liabilities | | | | | | | | | | | | | 73,200,000 | | | 87,500,000 | | | |
Long-term debt | [1] | | | | | | | | | | | | 368,700,000 | | | 194,600,000 | | | |
Total liabilities | | | | | | | | | | | | | 638,800,000 | | | 472,500,000 | | | |
Total stockholders’ equity | | | | | | | | | | | | | 804,700,000 | | | 774,400,000 | 1,015,900,000 | 1,084,200,000 | |
Total | | | | | | | | | | | | | $ 1,443,500,000 | | | 1,246,900,000 | | | |
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME | | | | | | | | | | | | | | | | | | | |
Net sales | | 331,900,000 | $ 320,600,000 | $ 334,900,000 | 343,200,000 | 316,600,000 | $ 336,400,000 | $ 367,200,000 | 371,700,000 | 1,330,600,000 | 1,391,900,000 | 1,356,100,000 | | | | | | | |
Cost of products sold: | | | | | | | | | | | | | | | | | | | |
Cost of products sold, excluding depreciation and amortization and other items | | 252,400,000 | 254,700,000 | 250,400,000 | 262,000,000 | 251,000,000 | 267,300,000 | 294,800,000 | 302,300,000 | 1,019,500,000 | 1,115,400,000 | 1,117,500,000 | | | | | | | |
Lower of cost or market inventory write-down | | 0 | 0 | 0 | 4,900,000 | 2,600,000 | 0 | 0 | 0 | 4,900,000 | 2,600,000 | 0 | | | | | | | |
Unrealized (gain) loss on derivative instruments | | (1,800,000) | (2,000,000) | (10,900,000) | (4,000,000) | (4,300,000) | 1,700,000 | 1,500,000 | 4,500,000 | (18,700,000) | 3,400,000 | 10,400,000 | | | | | | | |
Depreciation and amortization | | | | | | | | | | 36,000,000 | 32,400,000 | 31,100,000 | | | | | | | |
Selling, general, administrative, research and development | | | | | | | | | | 105,000,000 | 88,100,000 | 81,400,000 | | | | | | | |
Net periodic postretirement benefit cost (income) relating to VEBAs – Note 6 | | | | | | | | | | 3,400,000 | 2,400,000 | (23,700,000) | | | | | | | |
(Gain) loss on removal of Union VEBA net assets – Note 6 | | | | | | | | | | (100,000) | 493,400,000 | 0 | | | | | | | |
Total selling, administrative, research and development and general | | | | | | | | | | 108,300,000 | 583,900,000 | 57,700,000 | | | | | | | |
Other operating charges, net | | | | | | | | | | 2,800,000 | 100,000 | 1,500,000 | | | | | | | |
Total costs and expenses | | | | | | | | | | 1,152,800,000 | 1,737,800,000 | 1,218,200,000 | | | | | | | |
Operating (loss) income | | 45,300,000 | 29,800,000 | 57,900,000 | 44,800,000 | 35,200,000 | 40,500,000 | 37,000,000 | (458,600,000) | 177,800,000 | (345,900,000) | 137,900,000 | | | | | | | |
Interest expense | | | | | | | | | | (20,300,000) | (24,100,000) | (37,500,000) | | | | | | | |
Other (expense) income: | | | | | | | | | | | | | | | | | | | |
Other income, net | | | | | | | | | | (10,300,000) | (1,800,000) | 6,700,000 | | | | | | | |
(Loss) income before income taxes | | | | | | | | | | 147,200,000 | (371,800,000) | 107,100,000 | | | | | | | |
Income tax provision | | | | | | | | | | (55,500,000) | 135,200,000 | (35,300,000) | | | | | | | |
Earnings in equity of subsidiaries | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
Net income (loss) | | 24,500,000 | $ 14,900,000 | $ 26,000,000 | 26,300,000 | 13,300,000 | $ 22,100,000 | $ 20,200,000 | (292,200,000) | 91,700,000 | (236,600,000) | 71,800,000 | | | | | | | |
Comprehensive (loss) income | | | | | | | | | | 86,700,000 | (172,200,000) | (3,600,000) | | | | | | | |
Cash flows from operating activities: | | | | | | | | | | | | | | | | | | | |
Net cash (used in) provided by operating activities | | | | | | | | | | 164,300,000 | 158,800,000 | 124,100,000 | | | | | | | |
Cash flows from investing activities: | | | | | | | | | | | | | | | | | | | |
Capital expenditures | | | | | | | | | | (76,100,000) | (63,100,000) | (59,400,000) | | | | | | | |
Purchase of available for sale securities | | | | | | | | | | (255,300,000) | (500,000) | (93,500,000) | | | | | | | |
Proceeds from disposition of available for sale securities | | | | | | | | | | 55,000,000 | 84,000,000 | 108,200,000 | | | | | | | |
Intercompany loans receivable | | | | | | | | | | 0 | | | | | | | | | |
Net cash (used in) provided by investing activities | [3] | | | | | | | | | (276,400,000) | 20,400,000 | (44,700,000) | | | | | | | |
Cash flows from financing activities: | | | | | | | | | | | | | | | | | | | |
Repayment of principal and redemption premium of 8.25% Senior Notes | [4] | | | | | | | | | (206,000,000) | (30,000,000) | 0 | | | | | | | |
Issuance of 5.875% Senior Notes | | | | | | | | | | 375,000,000 | 0 | 0 | | | | | | | |
Cash paid for debt issuance costs | | | | | | | | | | (6,800,000) | (600,000) | | | | | | | | |
Proceeds from stock option exercises | | | | | | | | | | 1,200,000 | 0 | 0 | | | | | | | |
Repayment of Convertible Notes | [5] | | | | | | | | | 0 | (175,000,000) | 0 | | | | | | | |
Proceeds from cash-settled call options related to settlement of Convertible Notes | [5] | | | | | | | | | 0 | 94,900,000 | 0 | | | | | | | |
Payment for conversion premium related to settlement of Convertible Notes | [4] | | | | | | | | | 0 | (94,900,000) | 0 | | | | | | | |
Repayment of capital lease | | | | | | | | | | 0 | 0 | (100,000) | | | | | | | |
Excess tax benefit upon vesting of non-vested shares and dividend payment on unvested shares expected to vest | | | | | | | | | | 0 | 1,300,000 | 800,000 | | | | | | | |
Cancellation of shares to cover employees' tax withholdings upon vesting of non-vested shares | | | | | | | | | | (2,900,000) | (2,800,000) | (2,400,000) | | | | | | | |
Repurchase of common stock | | | | | | | | | | (33,300,000) | (49,200,000) | (44,100,000) | | | | | | | |
Cash dividends paid to stockholders | | | | | | | | | | (32,400,000) | (28,100,000) | (25,400,000) | | | | | | | |
Cash dividends paid to Parent | | | | | | | | | | 0 | | 0 | | | | | | | |
Intercompany loan | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
Net cash provided by (used in) financing activities | [3] | | | | | | | | | 94,800,000 | (284,400,000) | (71,200,000) | | | | | | | |
Net increase (decrease) in cash and cash equivalents during the period | | | | | | | | | | (17,300,000) | (105,200,000) | 8,200,000 | | | | | | | |
Cash and cash equivalents at beginning of period | | | | | 72,500,000 | | | | 177,700,000 | 72,500,000 | 177,700,000 | 169,500,000 | | | | | | | |
Cash and cash equivalents at end of period | | 55,200,000 | | | | 72,500,000 | | | | 55,200,000 | 72,500,000 | 177,700,000 | | | | | | | |
Ownership interest by parent | | | | | | | | | | | | | 100.00% | | | | | | |
Parent | | | | | | | | | | | | | | | | | | | |
Current assets: | | | | | | | | | | | | | | | | | | | |
Cash and cash equivalents | | 0 | | | 0 | 0 | | | 0 | 0 | 0 | 5,000,000 | $ 0 | | | 0 | 0 | 5,000,000 | |
Short-term investments | | | | | | | | | | | | | 0 | | | 0 | | | |
Receivables: | | | | | | | | | | | | | | | | | | | |
Trade, less allowance for doubtful receivables | | | | | | | | | | | | | 0 | | | 0 | | | |
Intercompany receivables | | | | | | | | | | | | | 85,800,000 | | | 0 | | | |
Other | | | | | | | | | | | | | 0 | | | 0 | | | |
Inventories | | | | | | | | | | | | | 0 | | | 0 | | | |
Prepaid expenses and other current assets | | | | | | | | | | | | | 100,000 | | | 200,000 | | | |
Total current assets | | | | | | | | | | | | | 85,900,000 | | | 200,000 | | | |
Investments in and advances to unconsolidated affiliates | | | | | | | | | | | | | 1,012,400,000 | | | 1,077,200,000 | | | |
Property, plant and equipment – net | | | | | | | | | | | | | 0 | | | 0 | | | |
Long-term intercompany receivables | | | | | | | | | | | | | 80,200,000 | | | 0 | | | |
Deferred tax assets — net | | | | | | | | | | | | | 0 | | | 0 | | | |
Intangible assets – net | | | | | | | | | | | | | 0 | | | 0 | | | |
Goodwill | | | | | | | | | | | | | 0 | | | 0 | | | |
Other assets | | | | | | | | | | | | | 0 | | | 0 | | | |
Total | | | | | | | | | | | | | 1,178,500,000 | | | 1,077,400,000 | | | |
Current liabilities: | | | | | | | | | | | | | | | | | | | |
Accounts payable | | | | | | | | | | | | | 2,200,000 | | | 500,000 | | | |
Intercompany payable | | | | | | | | | | | | | 0 | | | 106,500,000 | | | |
Accrued salaries, wages and related expenses | | | | | | | | | | | | | 0 | | | 0 | | | |
Other accrued liabilities | | | | | | | | | | | | | 2,900,000 | | | 1,400,000 | | | |
Short-term capital leases | | | | | | | | | | | | | 0 | | | 0 | | | |
Total current liabilities | | | | | | | | | | | | | 5,100,000 | | | 108,400,000 | | | |
Net liabilities of Salaried VEBA | | | | | | | | | | | | | 0 | | | 0 | | | |
Deferred tax liabilities | | | | | | | | | | | | | 0 | | | 0 | | | |
Long-term intercompany payable | | | | | | | | | | | | | 0 | | | 0 | | | |
Long-term liabilities | | | | | | | | | | | | | 0 | | | 0 | | | |
Long-term debt | | | | | | | | | | | | | 368,700,000 | | | 194,600,000 | | | |
Total liabilities | | | | | | | | | | | | | 373,800,000 | | | 303,000,000 | | | |
Total stockholders’ equity | | | | | | | | | | | | | 804,700,000 | | | 774,400,000 | | | |
Total | | | | | | | | | | | | | 1,178,500,000 | | | 1,077,400,000 | | | |
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME | | | | | | | | | | | | | | | | | | | |
Net sales | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
Cost of products sold: | | | | | | | | | | | | | | | | | | | |
Cost of products sold, excluding depreciation and amortization and other items | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
Lower of cost or market inventory write-down | | | | | | | | | | 0 | 0 | | | | | | | | |
Unrealized (gain) loss on derivative instruments | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
Depreciation and amortization | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
Selling, general, administrative, research and development | | | | | | | | | | 4,200,000 | 4,300,000 | 4,100,000 | | | | | | | |
Net periodic postretirement benefit cost (income) relating to VEBAs – Note 6 | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
(Gain) loss on removal of Union VEBA net assets – Note 6 | | | | | | | | | | 0 | 0 | | | | | | | | |
Total selling, administrative, research and development and general | | | | | | | | | | 4,200,000 | 4,300,000 | 4,100,000 | | | | | | | |
Other operating charges, net | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
Total costs and expenses | | | | | | | | | | 4,200,000 | 4,300,000 | 4,100,000 | | | | | | | |
Operating (loss) income | | | | | | | | | | (4,200,000) | (4,300,000) | (4,100,000) | | | | | | | |
Interest expense | | | | | | | | | | (21,600,000) | (23,500,000) | (37,500,000) | | | | | | | |
Other (expense) income: | | | | | | | | | | | | | | | | | | | |
Other income, net | | | | | | | | | | (11,100,000) | (2,500,000) | 3,700,000 | | | | | | | |
(Loss) income before income taxes | | | | | | | | | | (36,900,000) | (30,300,000) | (37,900,000) | | | | | | | |
Income tax provision | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
Earnings in equity of subsidiaries | | | | | | | | | | 128,600,000 | (206,300,000) | 109,700,000 | | | | | | | |
Net income (loss) | | | | | | | | | | 91,700,000 | (236,600,000) | 71,800,000 | | | | | | | |
Comprehensive (loss) income | | | | | | | | | | 86,700,000 | (172,200,000) | (3,600,000) | | | | | | | |
Cash flows from operating activities: | | | | | | | | | | | | | | | | | | | |
Net cash (used in) provided by operating activities | | | | | | | | | | 177,700,000 | 285,700,000 | 35,600,000 | | | | | | | |
Cash flows from investing activities: | | | | | | | | | | | | | | | | | | | |
Capital expenditures | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
Purchase of available for sale securities | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
Proceeds from disposition of available for sale securities | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
Intercompany loans receivable | | | | | | | | | | (166,000,000) | | | | | | | | | |
Net cash (used in) provided by investing activities | | | | | | | | | | (166,000,000) | 0 | 0 | | | | | | | |
Cash flows from financing activities: | | | | | | | | | | | | | | | | | | | |
Repayment of principal and redemption premium of 8.25% Senior Notes | | | | | | | | | | (206,000,000) | (30,000,000) | | | | | | | | |
Issuance of 5.875% Senior Notes | | | | | | | | | | 375,000,000 | | | | | | | | | |
Cash paid for debt issuance costs | | | | | | | | | | (6,800,000) | (600,000) | | | | | | | | |
Proceeds from stock option exercises | | | | | | | | | | 1,200,000 | | | | | | | | | |
Repayment of Convertible Notes | | | | | | | | | | | (175,000,000) | | | | | | | | |
Proceeds from cash-settled call options related to settlement of Convertible Notes | | | | | | | | | | | 94,900,000 | | | | | | | | |
Payment for conversion premium related to settlement of Convertible Notes | | | | | | | | | | | (94,900,000) | | | | | | | | |
Repayment of capital lease | | | | | | | | | | | | 0 | | | | | | | |
Excess tax benefit upon vesting of non-vested shares and dividend payment on unvested shares expected to vest | | | | | | | | | | | 0 | 0 | | | | | | | |
Cancellation of shares to cover employees' tax withholdings upon vesting of non-vested shares | | | | | | | | | | (2,900,000) | (2,800,000) | (2,400,000) | | | | | | | |
Repurchase of common stock | | | | | | | | | | (33,300,000) | (49,200,000) | (44,100,000) | | | | | | | |
Cash dividends paid to stockholders | | | | | | | | | | (32,400,000) | (28,100,000) | (25,400,000) | | | | | | | |
Cash dividends paid to Parent | | | | | | | | | | 0 | | 0 | | | | | | | |
Intercompany loan | | | | | | | | | | (106,500,000) | 0 | 31,300,000 | | | | | | | |
Net cash provided by (used in) financing activities | | | | | | | | | | (11,700,000) | (285,700,000) | (40,600,000) | | | | | | | |
Net increase (decrease) in cash and cash equivalents during the period | | | | | | | | | | 0 | 0 | (5,000,000) | | | | | | | |
Cash and cash equivalents at beginning of period | | | | | 0 | | | | 0 | 0 | 0 | 5,000,000 | | | | | | | |
Cash and cash equivalents at end of period | | 0 | | | | 0 | | | | 0 | 0 | 0 | | | | | | | |
Guarantor Subsidiaries | | | | | | | | | | | | | | | | | | | |
Current assets: | | | | | | | | | | | | | | | | | | | |
Cash and cash equivalents | | 52,900,000 | | | 72,200,000 | 72,200,000 | | | 175,300,000 | 72,200,000 | 175,300,000 | 157,700,000 | 52,900,000 | | | 72,200,000 | 175,300,000 | 157,700,000 | |
Short-term investments | | | | | | | | | | | | | 231,000,000 | | | 30,000,000 | | | |
Receivables: | | | | | | | | | | | | | | | | | | | |
Trade, less allowance for doubtful receivables | | | | | | | | | | | | | 133,100,000 | | | 114,000,000 | | | |
Intercompany receivables | | | | | | | | | | | | | 100,000 | | | 111,200,000 | | | |
Other | | | | | | | | | | | | | 11,400,000 | | | 3,800,000 | | | |
Inventories | | | | | | | | | | | | | 197,500,000 | | | 216,300,000 | | | |
Prepaid expenses and other current assets | | | | | | | | | | | | | 18,000,000 | | | 56,200,000 | | | |
Total current assets | | | | | | | | | | | | | 644,000,000 | | | 603,700,000 | | | |
Investments in and advances to unconsolidated affiliates | | | | | | | | | | | | | 40,100,000 | | | 31,400,000 | | | |
Property, plant and equipment – net | | | | | | | | | | | | | 499,500,000 | | | 464,300,000 | | | |
Long-term intercompany receivables | | | | | | | | | | | | | 0 | | | 0 | | | |
Deferred tax assets — net | | | | | | | | | | | | | 154,900,000 | | | 155,600,000 | | | |
Intangible assets – net | | | | | | | | | | | | | 26,400,000 | | | 30,500,000 | | | |
Goodwill | | | | | | | | | | | | | 37,200,000 | | | 37,200,000 | | | |
Other assets | | | | | | | | | | | | | 33,400,000 | | | 19,500,000 | | | |
Total | | | | | | | | | | | | | 1,435,500,000 | | | 1,342,200,000 | | | |
Current liabilities: | | | | | | | | | | | | | | | | | | | |
Accounts payable | | | | | | | | | | | | | 68,900,000 | | | 73,600,000 | | | |
Intercompany payable | | | | | | | | | | | | | 86,400,000 | | | 14,800,000 | | | |
Accrued salaries, wages and related expenses | | | | | | | | | | | | | 47,200,000 | | | 38,300,000 | | | |
Other accrued liabilities | | | | | | | | | | | | | 52,400,000 | | | 52,300,000 | | | |
Short-term capital leases | | | | | | | | | | | | | 200,000 | | | 100,000 | | | |
Total current liabilities | | | | | | | | | | | | | 255,100,000 | | | 179,100,000 | | | |
Net liabilities of Salaried VEBA | | | | | | | | | | | | | 28,600,000 | | | 19,000,000 | | | |
Deferred tax liabilities | | | | | | | | | | | | | 0 | | | 0 | | | |
Long-term intercompany payable | | | | | | | | | | | | | 85,100,000 | | | 3,100,000 | | | |
Long-term liabilities | | | | | | | | | | | | | 70,500,000 | | | 81,300,000 | | | |
Long-term debt | | | | | | | | | | | | | 0 | | | 0 | | | |
Total liabilities | | | | | | | | | | | | | 439,300,000 | | | 282,500,000 | | | |
Total stockholders’ equity | | | | | | | | | | | | | 996,200,000 | | | 1,059,700,000 | | | |
Total | | | | | | | | | | | | | 1,435,500,000 | | | 1,342,200,000 | | | |
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME | | | | | | | | | | | | | | | | | | | |
Net sales | | | | | | | | | | 1,301,600,000 | 1,361,600,000 | 1,323,400,000 | | | | | | | |
Cost of products sold: | | | | | | | | | | | | | | | | | | | |
Cost of products sold, excluding depreciation and amortization and other items | | | | | | | | | | 1,000,600,000 | 1,095,600,000 | 1,098,300,000 | | | | | | | |
Lower of cost or market inventory write-down | | | | | | | | | | 4,900,000 | 2,600,000 | | | | | | | | |
Unrealized (gain) loss on derivative instruments | | | | | | | | | | (18,700,000) | 3,400,000 | 10,400,000 | | | | | | | |
Depreciation and amortization | | | | | | | | | | 34,000,000 | 31,300,000 | 30,000,000 | | | | | | | |
Selling, general, administrative, research and development | | | | | | | | | | 95,000,000 | 76,500,000 | 69,700,000 | | | | | | | |
Net periodic postretirement benefit cost (income) relating to VEBAs – Note 6 | | | | | | | | | | 3,400,000 | 2,400,000 | (23,700,000) | | | | | | | |
(Gain) loss on removal of Union VEBA net assets – Note 6 | | | | | | | | | | (100,000) | 493,400,000 | | | | | | | | |
Total selling, administrative, research and development and general | | | | | | | | | | 98,300,000 | 572,300,000 | 46,000,000 | | | | | | | |
Other operating charges, net | | | | | | | | | | 2,800,000 | 100,000 | 1,500,000 | | | | | | | |
Total costs and expenses | | | | | | | | | | 1,121,900,000 | 1,705,300,000 | 1,186,200,000 | | | | | | | |
Operating (loss) income | | | | | | | | | | 179,700,000 | (343,700,000) | 137,200,000 | | | | | | | |
Interest expense | | | | | | | | | | 1,200,000 | (900,000) | (600,000) | | | | | | | |
Other (expense) income: | | | | | | | | | | | | | | | | | | | |
Other income, net | | | | | | | | | | 900,000 | 3,500,000 | 3,200,000 | | | | | | | |
(Loss) income before income taxes | | | | | | | | | | 181,800,000 | (341,100,000) | 139,800,000 | | | | | | | |
Income tax provision | | | | | | | | | | (69,000,000) | 122,500,000 | (50,200,000) | | | | | | | |
Earnings in equity of subsidiaries | | | | | | | | | | 1,700,000 | 900,000 | 6,000,000 | | | | | | | |
Net income (loss) | | | | | | | | | | 114,500,000 | (217,700,000) | 95,600,000 | | | | | | | |
Comprehensive (loss) income | | | | | | | | | | 109,800,000 | (153,500,000) | 19,900,000 | | | | | | | |
Cash flows from operating activities: | | | | | | | | | | | | | | | | | | | |
Net cash (used in) provided by operating activities | | | | | | | | | | 177,300,000 | (127,200,000) | 351,800,000 | | | | | | | |
Cash flows from investing activities: | | | | | | | | | | | | | | | | | | | |
Capital expenditures | | | | | | | | | | (74,000,000) | (47,900,000) | (56,400,000) | | | | | | | |
Purchase of available for sale securities | | | | | | | | | | (255,300,000) | (500,000) | (93,500,000) | | | | | | | |
Proceeds from disposition of available for sale securities | | | | | | | | | | 55,000,000 | 84,000,000 | 108,200,000 | | | | | | | |
Intercompany loans receivable | | | | | | | | | | 110,400,000 | | | | | | | | | |
Net cash (used in) provided by investing activities | | | | | | | | | | (163,900,000) | 35,600,000 | (41,700,000) | | | | | | | |
Cash flows from financing activities: | | | | | | | | | | | | | | | | | | | |
Repayment of principal and redemption premium of 8.25% Senior Notes | | | | | | | | | | 0 | 0 | | | | | | | | |
Issuance of 5.875% Senior Notes | | | | | | | | | | 0 | | | | | | | | | |
Cash paid for debt issuance costs | | | | | | | | | | 0 | 0 | | | | | | | | |
Proceeds from stock option exercises | | | | | | | | | | 0 | | | | | | | | | |
Repayment of Convertible Notes | | | | | | | | | | | 0 | | | | | | | | |
Proceeds from cash-settled call options related to settlement of Convertible Notes | | | | | | | | | | | 0 | | | | | | | | |
Payment for conversion premium related to settlement of Convertible Notes | | | | | | | | | | | 0 | | | | | | | | |
Repayment of capital lease | | | | | | | | | | | | (100,000) | | | | | | | |
Excess tax benefit upon vesting of non-vested shares and dividend payment on unvested shares expected to vest | | | | | | | | | | | 1,300,000 | 800,000 | | | | | | | |
Cancellation of shares to cover employees' tax withholdings upon vesting of non-vested shares | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
Repurchase of common stock | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
Cash dividends paid to stockholders | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
Cash dividends paid to Parent | | | | | | | | | | (200,000,000) | | (270,000,000) | | | | | | | |
Intercompany loan | | | | | | | | | | 167,300,000 | (12,800,000) | (23,200,000) | | | | | | | |
Net cash provided by (used in) financing activities | | | | | | | | | | (32,700,000) | (11,500,000) | (292,500,000) | | | | | | | |
Net increase (decrease) in cash and cash equivalents during the period | | | | | | | | | | (19,300,000) | (103,100,000) | 17,600,000 | | | | | | | |
Cash and cash equivalents at beginning of period | | | | | 72,200,000 | | | | 175,300,000 | 72,200,000 | 175,300,000 | 157,700,000 | | | | | | | |
Cash and cash equivalents at end of period | | 52,900,000 | | | | 72,200,000 | | | | 52,900,000 | 72,200,000 | 175,300,000 | | | | | | | |
Non-Guarantor Subsidiaries | | | | | | | | | | | | | | | | | | | |
Current assets: | | | | | | | | | | | | | | | | | | | |
Cash and cash equivalents | | 2,300,000 | | | 300,000 | 300,000 | | | 2,400,000 | 300,000 | 2,400,000 | 6,800,000 | 2,300,000 | | | 300,000 | 2,400,000 | 6,800,000 | |
Short-term investments | | | | | | | | | | | | | 0 | | | 0 | | | |
Receivables: | | | | | | | | | | | | | | | | | | | |
Trade, less allowance for doubtful receivables | | | | | | | | | | | | | 4,600,000 | | | 2,700,000 | | | |
Intercompany receivables | | | | | | | | | | | | | 600,000 | | | 1,100,000 | | | |
Other | | | | | | | | | | | | | 500,000 | | | 2,300,000 | | | |
Inventories | | | | | | | | | | | | | 8,000,000 | | | 6,600,000 | | | |
Prepaid expenses and other current assets | | | | | | | | | | | | | 900,000 | | | 1,700,000 | | | |
Total current assets | | | | | | | | | | | | | 16,900,000 | | | 14,700,000 | | | |
Investments in and advances to unconsolidated affiliates | | | | | | | | | | | | | 0 | | | 0 | | | |
Property, plant and equipment – net | | | | | | | | | | | | | 31,400,000 | | | 31,100,000 | | | |
Long-term intercompany receivables | | | | | | | | | | | | | 4,900,000 | | | 3,100,000 | | | |
Deferred tax assets — net | | | | | | | | | | | | | 0 | | | 0 | | | |
Intangible assets – net | | | | | | | | | | | | | 0 | | | 0 | | | |
Goodwill | | | | | | | | | | | | | 0 | | | 0 | | | |
Other assets | | | | | | | | | | | | | 0 | | | 100,000 | | | |
Total | | | | | | | | | | | | | 53,200,000 | | | 49,000,000 | | | |
Current liabilities: | | | | | | | | | | | | | | | | | | | |
Accounts payable | | | | | | | | | | | | | 4,700,000 | | | 2,600,000 | | | |
Intercompany payable | | | | | | | | | | | | | 100,000 | | | 4,000,000 | | | |
Accrued salaries, wages and related expenses | | | | | | | | | | | | | 1,900,000 | | | 1,500,000 | | | |
Other accrued liabilities | | | | | | | | | | | | | (700,000) | | | 400,000 | | | |
Short-term capital leases | | | | | | | | | | | | | 0 | | | 0 | | | |
Total current liabilities | | | | | | | | | | | | | 6,000,000 | | | 8,500,000 | | | |
Net liabilities of Salaried VEBA | | | | | | | | | | | | | 0 | | | 0 | | | |
Deferred tax liabilities | | | | | | | | | | | | | 3,300,000 | | | 2,100,000 | | | |
Long-term intercompany payable | | | | | | | | | | | | | 0 | | | 0 | | | |
Long-term liabilities | | | | | | | | | | | | | 2,700,000 | | | 6,200,000 | | | |
Long-term debt | | | | | | | | | | | | | 0 | | | 0 | | | |
Total liabilities | | | | | | | | | | | | | 12,000,000 | | | 16,800,000 | | | |
Total stockholders’ equity | | | | | | | | | | | | | 41,200,000 | | | 32,200,000 | | | |
Total | | | | | | | | | | | | | 53,200,000 | | | 49,000,000 | | | |
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME | | | | | | | | | | | | | | | | | | | |
Net sales | | | | | | | | | | 103,400,000 | 123,300,000 | 133,900,000 | | | | | | | |
Cost of products sold: | | | | | | | | | | | | | | | | | | | |
Cost of products sold, excluding depreciation and amortization and other items | | | | | | | | | | 90,000,000 | 108,400,000 | 117,800,000 | | | | | | | |
Lower of cost or market inventory write-down | | | | | | | | | | 0 | 0 | | | | | | | | |
Unrealized (gain) loss on derivative instruments | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
Depreciation and amortization | | | | | | | | | | 2,000,000 | 1,100,000 | 1,100,000 | | | | | | | |
Selling, general, administrative, research and development | | | | | | | | | | 8,400,000 | 9,300,000 | 9,900,000 | | | | | | | |
Net periodic postretirement benefit cost (income) relating to VEBAs – Note 6 | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
(Gain) loss on removal of Union VEBA net assets – Note 6 | | | | | | | | | | 0 | 0 | | | | | | | | |
Total selling, administrative, research and development and general | | | | | | | | | | 8,400,000 | 9,300,000 | 9,900,000 | | | | | | | |
Other operating charges, net | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
Total costs and expenses | | | | | | | | | | 100,400,000 | 118,800,000 | 128,800,000 | | | | | | | |
Operating (loss) income | | | | | | | | | | 3,000,000 | 4,500,000 | 5,100,000 | | | | | | | |
Interest expense | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
Other (expense) income: | | | | | | | | | | | | | | | | | | | |
Other income, net | | | | | | | | | | 0 | (2,500,000) | 400,000 | | | | | | | |
(Loss) income before income taxes | | | | | | | | | | 3,000,000 | 2,000,000 | 5,500,000 | | | | | | | |
Income tax provision | | | | | | | | | | (600,000) | 1,300,000 | 800,000 | | | | | | | |
Earnings in equity of subsidiaries | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
Net income (loss) | | | | | | | | | | 2,400,000 | 3,300,000 | 6,300,000 | | | | | | | |
Comprehensive (loss) income | | | | | | | | | | 2,100,000 | 3,500,000 | 6,600,000 | | | | | | | |
Cash flows from operating activities: | | | | | | | | | | | | | | | | | | | |
Net cash (used in) provided by operating activities | | | | | | | | | | 9,300,000 | 300,000 | 6,700,000 | | | | | | | |
Cash flows from investing activities: | | | | | | | | | | | | | | | | | | | |
Capital expenditures | | | | | | | | | | (2,100,000) | (15,200,000) | (3,000,000) | | | | | | | |
Purchase of available for sale securities | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
Proceeds from disposition of available for sale securities | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
Intercompany loans receivable | | | | | | | | | | (1,300,000) | | | | | | | | | |
Net cash (used in) provided by investing activities | | | | | | | | | | (3,400,000) | (15,200,000) | (3,000,000) | | | | | | | |
Cash flows from financing activities: | | | | | | | | | | | | | | | | | | | |
Repayment of principal and redemption premium of 8.25% Senior Notes | | | | | | | | | | 0 | 0 | | | | | | | | |
Issuance of 5.875% Senior Notes | | | | | | | | | | 0 | | | | | | | | | |
Cash paid for debt issuance costs | | | | | | | | | | 0 | 0 | | | | | | | | |
Proceeds from stock option exercises | | | | | | | | | | 0 | | | | | | | | | |
Repayment of Convertible Notes | | | | | | | | | | | 0 | | | | | | | | |
Proceeds from cash-settled call options related to settlement of Convertible Notes | | | | | | | | | | | 0 | | | | | | | | |
Payment for conversion premium related to settlement of Convertible Notes | | | | | | | | | | | 0 | | | | | | | | |
Repayment of capital lease | | | | | | | | | | | | 0 | | | | | | | |
Excess tax benefit upon vesting of non-vested shares and dividend payment on unvested shares expected to vest | | | | | | | | | | | 0 | 0 | | | | | | | |
Cancellation of shares to cover employees' tax withholdings upon vesting of non-vested shares | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
Repurchase of common stock | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
Cash dividends paid to stockholders | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
Cash dividends paid to Parent | | | | | | | | | | 0 | | 0 | | | | | | | |
Intercompany loan | | | | | | | | | | (3,900,000) | 12,800,000 | (8,100,000) | | | | | | | |
Net cash provided by (used in) financing activities | | | | | | | | | | (3,900,000) | 12,800,000 | (8,100,000) | | | | | | | |
Net increase (decrease) in cash and cash equivalents during the period | | | | | | | | | | 2,000,000 | (2,100,000) | (4,400,000) | | | | | | | |
Cash and cash equivalents at beginning of period | | | | | 300,000 | | | | 2,400,000 | 300,000 | 2,400,000 | 6,800,000 | | | | | | | |
Cash and cash equivalents at end of period | | 2,300,000 | | | | 300,000 | | | | 2,300,000 | 300,000 | 2,400,000 | | | | | | | |
Senior Notes | Senior Notes Due 2024 [Member] | | | | | | | | | | | | | | | | | | | |
Cash flows from financing activities: | | | | | | | | | | | | | | | | | | | |
Principal amount of notes | | | | | | | | | | | | | | | $ 375,000,000 | | | | |
Debt Instrument, Interest Rate, Stated Percentage | | | | | | | | | | | | | | | 5.875% | | | | |
Senior Notes | Senior Notes Due 2020 | | | | | | | | | | | | | | | | | | | |
Current liabilities: | | | | | | | | | | | | | | | | | | | |
Long-term debt | | | | | | | | | | | | | | $ 197,800,000 | | | | | |
Cash flows from financing activities: | | | | | | | | | | | | | | | | | | | |
Repayment of principal and redemption premium of 8.25% Senior Notes | | | | | | | | | | | (30,000,000) | | | | | | | | |
Principal amount of notes | | | | | | | | | | | | | | | | | | | $ 225,000,000 |
Debt Instrument, Interest Rate, Stated Percentage | | | | | | | | | | | | | | | | | | | 8.25% |
Consolidating Adjustments | | | | | | | | | | | | | | | | | | | |
Current assets: | | | | | | | | | | | | | | | | | | | |
Cash and cash equivalents | | 0 | | | 0 | 0 | | | 0 | 0 | 0 | 0 | 0 | | | 0 | $ 0 | $ 0 | |
Short-term investments | | | | | | | | | | | | | 0 | | | 0 | | | |
Receivables: | | | | | | | | | | | | | | | | | | | |
Trade, less allowance for doubtful receivables | | | | | | | | | | | | | 0 | | | 0 | | | |
Intercompany receivables | | | | | | | | | | | | | (86,500,000) | | | (112,300,000) | | | |
Other | | | | | | | | | | | | | 0 | | | 0 | | | |
Inventories | | | | | | | | | | | | | (3,900,000) | | | (3,300,000) | | | |
Prepaid expenses and other current assets | | | | | | | | | | | | | (500,000) | | | (1,400,000) | | | |
Total current assets | | | | | | | | | | | | | (90,900,000) | | | (117,000,000) | | | |
Investments in and advances to unconsolidated affiliates | | | | | | | | | | | | | (1,052,500,000) | | | (1,108,600,000) | | | |
Property, plant and equipment – net | | | | | | | | | | | | | 0 | | | 0 | | | |
Long-term intercompany receivables | | | | | | | | | | | | | (85,100,000) | | | (3,100,000) | | | |
Deferred tax assets — net | | | | | | | | | | | | | 4,800,000 | | | 7,000,000 | | | |
Intangible assets – net | | | | | | | | | | | | | 0 | | | 0 | | | |
Goodwill | | | | | | | | | | | | | 0 | | | 0 | | | |
Other assets | | | | | | | | | | | | | 0 | | | 0 | | | |
Total | | | | | | | | | | | | | (1,223,700,000) | | | (1,221,700,000) | | | |
Current liabilities: | | | | | | | | | | | | | | | | | | | |
Accounts payable | | | | | | | | | | | | | 0 | | | 0 | | | |
Intercompany payable | | | | | | | | | | | | | (86,500,000) | | | (125,300,000) | | | |
Accrued salaries, wages and related expenses | | | | | | | | | | | | | 0 | | | 0 | | | |
Other accrued liabilities | | | | | | | | | | | | | (14,700,000) | | | (1,400,000) | | | |
Short-term capital leases | | | | | | | | | | | | | 0 | | | 0 | | | |
Total current liabilities | | | | | | | | | | | | | (101,200,000) | | | (126,700,000) | | | |
Net liabilities of Salaried VEBA | | | | | | | | | | | | | 0 | | | 0 | | | |
Deferred tax liabilities | | | | | | | | | | | | | 0 | | | 0 | | | |
Long-term intercompany payable | | | | | | | | | | | | | (85,100,000) | | | (3,100,000) | | | |
Long-term liabilities | | | | | | | | | | | | | 0 | | | 0 | | | |
Long-term debt | | | | | | | | | | | | | 0 | | | 0 | | | |
Total liabilities | | | | | | | | | | | | | (186,300,000) | | | (129,800,000) | | | |
Total stockholders’ equity | | | | | | | | | | | | | (1,037,400,000) | | | (1,091,900,000) | | | |
Total | | | | | | | | | | | | | $ (1,223,700,000) | | | $ (1,221,700,000) | | | |
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME | | | | | | | | | | | | | | | | | | | |
Net sales | | | | | | | | | | (74,400,000) | (93,000,000) | (101,200,000) | | | | | | | |
Cost of products sold: | | | | | | | | | | | | | | | | | | | |
Cost of products sold, excluding depreciation and amortization and other items | | | | | | | | | | (71,100,000) | (88,600,000) | (98,600,000) | | | | | | | |
Lower of cost or market inventory write-down | | | | | | | | | | 0 | 0 | | | | | | | | |
Unrealized (gain) loss on derivative instruments | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
Depreciation and amortization | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
Selling, general, administrative, research and development | | | | | | | | | | (2,600,000) | (2,000,000) | (2,300,000) | | | | | | | |
Net periodic postretirement benefit cost (income) relating to VEBAs – Note 6 | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
(Gain) loss on removal of Union VEBA net assets – Note 6 | | | | | | | | | | 0 | 0 | | | | | | | | |
Total selling, administrative, research and development and general | | | | | | | | | | (2,600,000) | (2,000,000) | (2,300,000) | | | | | | | |
Other operating charges, net | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
Total costs and expenses | | | | | | | | | | (73,700,000) | (90,600,000) | (100,900,000) | | | | | | | |
Operating (loss) income | | | | | | | | | | (700,000) | (2,400,000) | (300,000) | | | | | | | |
Interest expense | | | | | | | | | | 100,000 | 300,000 | 600,000 | | | | | | | |
Other (expense) income: | | | | | | | | | | | | | | | | | | | |
Other income, net | | | | | | | | | | (100,000) | (300,000) | (600,000) | | | | | | | |
(Loss) income before income taxes | | | | | | | | | | (700,000) | (2,400,000) | (300,000) | | | | | | | |
Income tax provision | | | | | | | | | | 14,100,000 | 11,400,000 | 14,100,000 | | | | | | | |
Earnings in equity of subsidiaries | | | | | | | | | | (130,300,000) | 205,400,000 | (115,700,000) | | | | | | | |
Net income (loss) | | | | | | | | | | (116,900,000) | 214,400,000 | (101,900,000) | | | | | | | |
Comprehensive (loss) income | | | | | | | | | | (111,900,000) | 150,000,000 | (26,500,000) | | | | | | | |
Cash flows from operating activities: | | | | | | | | | | | | | | | | | | | |
Net cash (used in) provided by operating activities | | | | | | | | | | (200,000,000) | 0 | (270,000,000) | | | | | | | |
Cash flows from investing activities: | | | | | | | | | | | | | | | | | | | |
Capital expenditures | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
Purchase of available for sale securities | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
Proceeds from disposition of available for sale securities | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
Intercompany loans receivable | | | | | | | | | | 56,900,000 | | | | | | | | | |
Net cash (used in) provided by investing activities | | | | | | | | | | 56,900,000 | 0 | 0 | | | | | | | |
Cash flows from financing activities: | | | | | | | | | | | | | | | | | | | |
Repayment of principal and redemption premium of 8.25% Senior Notes | | | | | | | | | | 0 | 0 | | | | | | | | |
Issuance of 5.875% Senior Notes | | | | | | | | | | 0 | | | | | | | | | |
Cash paid for debt issuance costs | | | | | | | | | | 0 | 0 | | | | | | | | |
Proceeds from stock option exercises | | | | | | | | | | 0 | | | | | | | | | |
Repayment of Convertible Notes | | | | | | | | | | | 0 | | | | | | | | |
Proceeds from cash-settled call options related to settlement of Convertible Notes | | | | | | | | | | | 0 | | | | | | | | |
Payment for conversion premium related to settlement of Convertible Notes | | | | | | | | | | | 0 | | | | | | | | |
Repayment of capital lease | | | | | | | | | | | | 0 | | | | | | | |
Excess tax benefit upon vesting of non-vested shares and dividend payment on unvested shares expected to vest | | | | | | | | | | | 0 | 0 | | | | | | | |
Cancellation of shares to cover employees' tax withholdings upon vesting of non-vested shares | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
Repurchase of common stock | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
Cash dividends paid to stockholders | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
Cash dividends paid to Parent | | | | | | | | | | 200,000,000 | | 270,000,000 | | | | | | | |
Intercompany loan | | | | | | | | | | (56,900,000) | 0 | 0 | | | | | | | |
Net cash provided by (used in) financing activities | | | | | | | | | | 143,100,000 | 0 | 270,000,000 | | | | | | | |
Net increase (decrease) in cash and cash equivalents during the period | | | | | | | | | | 0 | 0 | 0 | | | | | | | |
Cash and cash equivalents at beginning of period | | | | | $ 0 | | | | $ 0 | 0 | 0 | 0 | | | | | | | |
Cash and cash equivalents at end of period | | $ 0 | | | | $ 0 | | | | $ 0 | $ 0 | $ 0 | | | | | | | |
| |
[1] | See Note 1 for discussion of our adoption of ASU 2015-03 and ASU 2015-17 (as defined in Note 1). | |
[2] | See Note 5 and Note 8 for discussion of our adoption of ASU 2016-09 (as defined in Note 1). | |
[3] | See Note 13 for supplemental disclosure on non-cash transactions. | |
[4] | See Note 3 for more information relating to the 8.25% Senior Notes (defined in Note 3) and the Convertible Notes. | |
[5] | See Note 2 for the impact of reclassifying repair parts to other current and other long-term assets. | |